Trade

with

Hospira Inc
(NYSE: HSP)
US Markets Closed
AdChoices
50.08
-0.80
-1.57%
After Hours :
50.59
+0.51
+1.01%

Open

51.00

Previous Close

50.88

Volume (Avg)

1.28M (1.03M)

Day's Range

50.04-51.17

52Wk Range

38.11-56.78

Market Cap.

8.45B

Dividend Rate ( Yield )

-

Beta

0.54

Shares Outstanding

168.73M

P/E Ratio (EPS)

48.31 (1.04)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Drug Manufacturers – Specific & Generic
Highlights
Analyst Recommendation: Hold
    • Revenue

    • 4.00B

    • Net Income

    • -8.30M

    • Market Cap.

    • 8.45B

    • Enterprise Value

    • 9.56B

    • Net Profit Margin %

    • 4.07

    • PEG (Price/Earnings Growth) Ratio

    • 1.30

    • Beta

    • 0.54

    • Forward P/E

    • 20.75

    • Price/Sales

    • 2.00

    • Price/Book Value

    • 2.64

    • Price/Cash flow

    • 18.90

      • EBITDA

      • 220.50M

      • Return on Capital %

      • 2.81

      • Return on Equity %

      • 5.67

      • Return on Assets %

      • 2.81

      • Book Value/Share

      • 19.26

      • Shares Outstanding

      • 168.73M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Hold
        • 1 Year Price Target

        • 55.67

        • Credit Rating

        • BBB-

        • Analysts

        • 5

        • EPS Estimate

        • 2.05

        • Cashflow Estimate

        • 3.97

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 10.70

          • 7.67

          • Net Income

            YTD/YTD (last year)

          • -

          • -26.33

          • Net Income

            Q/Q (last year)

          • 115.50

          • 197.54

          • Sales (Revenue)

            5-Year Annual Average

          • 1.98

          • -5.42

          • Net Income

            5-Year Annual Average

          • -

          • 3.16

          • Dividends

            5-Year Annual Average

          • -

          • -0.13

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 32.28

            • 64.72

            • Pre-Tax Margin

            • 3.68

            • 13.77

            • Net Profit Margin

            • 4.07

            • 10.84

            • Average Gross Margin

              5-Year Annual Average

            • 33.00

            • 67.80

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 3.00

            • 15.58

            • Average Net Profit Margin

              5-Year Annual Average

            • 4.00

            • 343.47B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.54

              • 0.33

              • Current Ratio

              • 2.57

              • 1.52

              • Quick Ratio

              • 1.33

              • 0.87

              • Interest Coverage

              • 2.82

              • 6.77

              • Leverage Ratio

              • 1.97

              • 1.91

              • Book Value/Share

              • 19.26

              • 16.21

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 48.08

                • 63.69

                • P/E Ratio 5-Year High

                • 58.27

                • 237.47

                • P/E Ratio 5-Year Low

                • 25.93

                • 19.71

                • Price/Sales Ratio

                • 1.96

                • 3.64

                • Price/Book Value

                • 2.59

                • 3.39

                • Price/Cash Flow Ratio

                • 18.90

                • 21.79

                • Key Metrics

                • Company

                  • Shares Short

                    as of 9/30/2014

                  • 5.62M

                  • Short Ratio

                    as of 9/30/2014

                  • 7.31

                  • Short % of Float

                    as of 9/30/2014

                  • 3.87

                  • Shares Short

                    prior month

                  • 5.73M

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • 5.67

                        (6.30)

                      • 7.86

                        (9.58)

                      • Return on Assets %

                        (5-Year Average)

                      • 2.81

                        (2.90)

                      • 4.14

                        (5.54)

                      • Return on Capital %

                        (5-Year Average)

                      • 5.37

                        (2.00)

                      • 5.59

                        (7.66)

                      • Income/Employee

                      • 10.25k

                      • 27.79k

                      • Inventory Turnover

                      • 2.63

                      • 1.80

                      • Asset Turnover

                      • 0.69

                      • 0.38

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      16.60M
                      Operating Margin
                      0.41
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      18.90
                      Ownership

                      Institutional Ownership

                      98.62%

                      Top 10 Institutions

                      52.67%

                      Mutual Fund Ownership

                      59.90%

                      Float

                      87.03%

                      5% / Insider Ownership

                      0.92%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Health Care Fund

                      •  

                        8,375,170

                      • 0.00

                      • 4.97

                      • T. Rowe Price Mid Cap Value Fund

                      •  

                        5,139,526

                      • 1.56

                      • 3.05

                      • T. Rowe Price Mid Cap Growth Fund

                      •  

                        4,750,000

                      • 15.85

                      • 2.82

                      • Fidelity® Growth Company Fund

                      •  

                        4,382,040

                      • 0.69

                      • 2.60

                      • T. Rowe Price Value Fund

                      •  

                        4,330,000

                      • 71.49

                      • 2.57

                      • Franklin Mutual Global Discovery Fund

                      •  

                        3,562,996

                      • 0.00

                      • 2.11

                      • Vanguard Mid-Cap Index Fund

                      •  

                        2,886,639

                      • 2.05

                      • 1.71

                      • Vanguard Total Stock Mkt Idx

                      •  

                        2,746,531

                      • 1.34

                      • 1.63

                      • Franklin Mutual Shares Fund

                      •  

                        2,595,187

                      • 0.00

                      • 1.54

                      • ASTON/Fairpointe Mid Cap Fund

                      •  

                        1,866,495

                      • -14.50

                      • 1.11

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • T. Rowe Price Associates, Inc.

                      •  

                        22,842,928

                      • +21.91%

                      • 13.56

                      • Vanguard Group, Inc.

                      •  

                        11,790,142

                      • +2.84%

                      • 7.00

                      • Wellington Management Company, LLP

                      •  

                        11,699,958

                      • +3.03%

                      • 6.94

                      • Franklin Mutual Advisers, LLC

                      •  

                        10,828,968

                      • +9.93%

                      • 6.43

                      • State Street Corp

                      •  

                        7,063,182

                      • -0.99%

                      • 4.19

                      • Lateef Investment Management, L.p.

                      •  

                        6,555,485

                      • -6.28%

                      • 3.89

                      • Fidelity Management and Research Company

                      •  

                        5,268,363

                      • +29.45%

                      • 3.13

                      • BlackRock Fund Advisors

                      •  

                        5,087,126

                      • +2.23%

                      • 3.02

                      • Cramer Rosenthal McGlynn, LLC

                      •  

                        4,111,144

                      • -16.59%

                      • 2.44

                      • BlackRock Advisors LLC

                      •  

                        3,484,993

                      • +32.77%

                      • 2.07

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Drug Manufacturers – Specific & Generic

                      Type

                      Slow Growth

                      Style

                      Mid Core

                      Hospira, Inc. was incorporated in Delaware on September 16, 2003. The Company is a provider of injectable drugs and infusion technologies. Its portfolio includes generic acute-care and oncology injectables, as well as integrated infu...moresion therapy and medication management products. Its portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities. The Company conducts operations and is managed in three reportable segments: Americas; Europe, Middle East and Africa; and Asia Pacific. The Americas segment includes the United States, Canada and Latin America; the EMEA segment includes Europe, the Middle East and Africa; and the APAC segment includes Asia, Japan, Australia and New Zealand. The Company offers Specialty inje...morectable pharmaceutical, Medication management & other pharmaceuticals. The Company’s specialty injectable pharmaceutical product category mainly consists of generic injectable pharmaceuticals. These products provide customers with a lower-cost alternative to branded products, when the patent protection has expired, when patents have been declared invalid, or when the products do not infringe the patents of others. These drugs' therapeutic areas include analgesia, anesthesia, anti-infectives, cardiovascular, oncology, and other areas. The Company’s other pharmaceuticals mainly consist of large volume I.V. solution, nutritional and contract manufacturing services. The Company offers infusion therapy solutions and related supplies that include I.V. solutions for general use, I.V. nutrition products, and solutions for the washing and cleansing of wounds or surgical sites. Its contract manufacturing services are offered through its One2One(SM) services group. The Company’s medication management products include electronic drug delivery pumps, safety software and disposable administration sets dedicated to the company’s pumps. These sets are used to deliver I.V. fluids and medications. Medication management includes TheraDoc, Inc. products, which are module-based clinical surveillance systems that provide patient safety surveillance and clinical decision support. Medication management also includes gravity administration sets and other device products, including needlestick safety products and programs to support Hospira's customers. The Company’s main customers in the Americas segment include hospitals, wholesalers, integrated delivery networks and alternate site facilities. Its main customers in the EMEA and APAC segments are hospitals and wholesalers that serve through its own sales force and its distributors. In the U.S., the Company’s products are mainly distributed through a network of Company-operated distribution facilities and third-party logistics providers. The Company’s competitors in specialty injectable pharmaceuticals in the Americas segment include Baxter International Inc., Bedford Laboratories, Fresenius Kabi, Pfizer, Sandoz, Sanofi, Teva Pharmaceuticals. Its competitors in medication management include Baxter, B. Braun Melsungen AG, CareFusion, Fresenius Kabi and Terumo. In the EMEA segment, competitors include Teva, Sandoz, Actavis, Fresenius Kabi, Intas Pharmaceuticals, Ltd, Medac GmbH, Mylan Inc., Sun Pharmaceutical Industries, Ltd., and Baxter. The Company’s operations and business activities are subject to extensive legal and regulatory requirements that are enforced by numerous governmental agencies in the countries in which it does business.lessless

                      Key People

                      Mr. F. Michael Ball

                      CEO/Director

                      John C. Staley

                      Chairman of the Board/Director

                      Thomas E. Werner

                      CFO/Senior VP, Divisional

                      Daphne Jones

                      Chief Information Officer/Senior VP

                      Richard J. Hoffman

                      Chief Accounting Officer/Controller/Vice President

                      • Hospira Inc

                      • 275 North Field Drive

                      • Lake Forest, IL 60045

                      • USA.Map

                      • Phone: +1 224 212-2000

                      • Fax: -

                      • hospira.com

                      Incorporated

                      2003

                      Employees

                      17,000

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: